A virtual organization, founded in 1999, where all of its R&D, access and delivery activities are undertaken in collaboration with partners globally. Pharmaceutical and biotech partners bring expertise and facilities in drug discovery and development while academic research institutions bring scientific research expertise and facilities ranging from basic biology to clinical medicine and field expertise. It works to make its new anti-malarials accessible to vulnerable populations and collaborates with organizations ministries of health, the World Health Organization, private industry, NGOs and philanthropists. It also supports global consortia such as Roll Back Malaria and the Affordable Medicines Facility, to coordinate action on the eradication of malaria.